カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/04 | 1,248 | 1,248 | 1,175 | 1,184 | -41 | -3.3% | 11,500 |
| 2025/04/03 | 1,230 | 1,235 | 1,220 | 1,225 | -11 | -0.9% | 3,700 |
| 2025/04/02 | 1,235 | 1,236 | 1,235 | 1,236 | ±0 | ±0% | 200 |
| 2025/04/01 | 1,239 | 1,256 | 1,236 | 1,236 | -17 | -1.4% | 1,700 |
| 2025/03/31 | 1,230 | 1,253 | 1,229 | 1,253 | -4 | -0.3% | 1,000 |
| 2025/03/28 | 1,253 | 1,260 | 1,231 | 1,257 | -9 | -0.7% | 500 |
| 2025/03/27 | 1,268 | 1,268 | 1,256 | 1,266 | +7 | +0.6% | 8,000 |
| 2025/03/26 | 1,251 | 1,259 | 1,238 | 1,259 | -9 | -0.7% | 2,100 |
| 2025/03/25 | 1,277 | 1,285 | 1,253 | 1,268 | -9 | -0.7% | 3,000 |
| 2025/03/24 | 1,244 | 1,287 | 1,236 | 1,277 | +35 | +2.8% | 15,200 |
| 2025/03/21 | 1,242 | 1,242 | 1,237 | 1,242 | ±0 | ±0% | 1,300 |
| 2025/03/19 | 1,243 | 1,254 | 1,238 | 1,242 | -8 | -0.6% | 3,200 |
| 2025/03/18 | 1,251 | 1,253 | 1,241 | 1,250 | +4 | +0.3% | 600 |
| 2025/03/17 | 1,245 | 1,254 | 1,245 | 1,246 | -5 | -0.4% | 700 |
| 2025/03/14 | 1,241 | 1,257 | 1,237 | 1,251 | ±0 | ±0% | 1,300 |
| 2025/03/13 | 1,271 | 1,271 | 1,251 | 1,251 | +1 | +0.1% | 300 |
| 2025/03/12 | 1,237 | 1,250 | 1,237 | 1,250 | +13 | +1.1% | 300 |
| 2025/03/11 | 1,230 | 1,246 | 1,201 | 1,237 | -23 | -1.8% | 3,200 |
| 2025/03/10 | 1,255 | 1,272 | 1,250 | 1,260 | +5 | +0.4% | 2,400 |
| 2025/03/07 | 1,245 | 1,269 | 1,237 | 1,255 | +10 | +0.8% | 2,000 |
| 2025/03/06 | 1,234 | 1,246 | 1,234 | 1,245 | ±0 | ±0% | 1,100 |
| 2025/03/05 | 1,248 | 1,248 | 1,222 | 1,245 | +9 | +0.7% | 900 |
| 2025/03/04 | 1,245 | 1,245 | 1,235 | 1,236 | +4 | +0.3% | 600 |
| 2025/03/03 | 1,215 | 1,254 | 1,215 | 1,232 | +25 | +2.1% | 2,800 |
| 2025/02/28 | 1,219 | 1,220 | 1,205 | 1,207 | -12 | -1% | 1,600 |
| 2025/02/27 | 1,205 | 1,222 | 1,205 | 1,219 | +7 | +0.6% | 900 |
| 2025/02/26 | 1,212 | 1,212 | 1,212 | 1,212 | -1 | -0.1% | 300 |
| 2025/02/25 | 1,220 | 1,221 | 1,213 | 1,213 | -9 | -0.7% | 1,300 |
| 2025/02/21 | 1,212 | 1,222 | 1,212 | 1,222 | +10 | +0.8% | 1,200 |
| 2025/02/20 | 1,220 | 1,223 | 1,212 | 1,212 | -8 | -0.7% | 1,800 |
| 2025/02/19 | 1,224 | 1,224 | 1,217 | 1,220 | -4 | -0.3% | 400 |
| 2025/02/18 | 1,206 | 1,227 | 1,206 | 1,224 | +23 | +1.9% | 4,600 |
| 2025/02/17 | 1,200 | 1,209 | 1,200 | 1,201 | +3 | +0.3% | 1,100 |
| 2025/02/14 | 1,202 | 1,208 | 1,198 | 1,198 | -11 | -0.9% | 1,300 |
| 2025/02/13 | 1,200 | 1,211 | 1,200 | 1,209 | +9 | +0.8% | 1,400 |
| 2025/02/12 | 1,203 | 1,213 | 1,200 | 1,200 | -3 | -0.2% | 2,000 |
| 2025/02/10 | 1,209 | 1,218 | 1,201 | 1,203 | -5 | -0.4% | 1,300 |
| 2025/02/07 | 1,219 | 1,219 | 1,188 | 1,208 | +7 | +0.6% | 8,600 |
| 2025/02/06 | 1,202 | 1,210 | 1,201 | 1,201 | ±0 | ±0% | 1,500 |
| 2025/02/05 | 1,202 | 1,224 | 1,201 | 1,201 | -1 | -0.1% | 2,800 |
| 2025/02/04 | 1,205 | 1,210 | 1,202 | 1,202 | +1 | +0.1% | 1,100 |
| 2025/02/03 | 1,213 | 1,226 | 1,200 | 1,201 | -12 | -1% | 2,700 |
| 2025/01/31 | 1,200 | 1,222 | 1,180 | 1,213 | +13 | +1.1% | 4,200 |
| 2025/01/30 | 1,176 | 1,230 | 1,176 | 1,200 | +13 | +1.1% | 4,400 |
| 2025/01/29 | 1,180 | 1,200 | 1,180 | 1,187 | +1 | +0.1% | 2,200 |
| 2025/01/28 | 1,179 | 1,215 | 1,178 | 1,186 | -4 | -0.3% | 1,300 |
| 2025/01/27 | 1,226 | 1,237 | 1,159 | 1,190 | -35 | -2.9% | 14,400 |
| 2025/01/24 | 1,283 | 1,310 | 1,211 | 1,225 | -58 | -4.5% | 33,800 |
| 2025/01/23 | 1,281 | 1,292 | 1,275 | 1,283 | +3 | +0.2% | 4,400 |
| 2025/01/22 | 1,283 | 1,285 | 1,265 | 1,280 | -4 | -0.3% | 5,600 |
1～
50
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 118,400円 | +6.8% | -13.8% | 2.96% | 9.07倍 | 0.77倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| モダリス | 7,800円 | - | - | 0.00% | - | 1.63倍 |
|
遺伝子治療薬の創薬ベンチャー、ＤＮＡ切断しないエピゲノム編集に強み。研究開発中心は米国 |
| ティムス | 14,200円 | - | - | 0.00% | - | 1.93倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国ＣＯＲＸＥＬ社に導出 |
| クリングル | 78,700円 | +240.0% | - | 0.00% | - | 2.58倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| カルナバイオ | 25,900円 | +13.5% | - | 0.00% | - | 2.00倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム
